Human Monoclonal Antibodies as a New Class of Antiinfective Compounds

Human Monoclonal Antibodies as a New Class of Antiinfective Compounds

Saved in:

Bibliographic Details
Main Authors:	Roberto Burioni, Alois B. Lang, J. Donald Capra
Format:	Article
Language:	English
Published:	Wiley 2013-01-01
Series:	Clinical and Developmental Immunology
Online Access:	http://dx.doi.org/10.1155/2013/297120
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antiinfective, Antitoxic and Antiparasitic Effects of Exogenic DNA
by: N. N. Besednova, et al.
Published: (2020-05-01)

The Relevance of Using Topical Antiinfectives in the Combination Therapy of Acute Otitis Media in Children
by: A. A. Ayzenshtadt
Published: (2016-01-01)

Technological Advancements in Monoclonal Antibodies
by: José F. Santos-Neto, et al.
Published: (2021-01-01)

New approach to generating of human monoclonal antibodies specific to the proteolytic domain of botulinum neurotoxin A
by: Marina Vladimirovna Silkina, et al.
Published: (2024-07-01)

Human Monoclonal Antibody-Based Therapy in the Treatment of Invasive Candidiasis
by: Francesca Bugli, et al.
Published: (2013-01-01)

A combination of two human monoclonal antibodies cures symptomatic rabies
by: Guilherme Dias de Melo, et al.
Published: (2020-09-01)

Study on the monoclonal antibody to chlorpyrifos
by: JIN Ren-yao, et al.
Published: (2006-11-01)

Monoclonal Antibodies to the Thyrotropin Receptor
by: Takao Ando, et al.
Published: (2005-01-01)

The Use of Humanized Monoclonal Antibodies for the Prevention of Respiratory Syncytial Virus Infection
by: Marcello Lanari, et al.
Published: (2013-01-01)

NEW MONOCLONAL ANTIBODY FOR TUMOR-ASSOCIATED PROTEIN PMEPA1 DETECTION
by: V. V. Volkomorov, et al.
Published: (2016-02-01)

Monoclonal humanized monovalent antibody blocking therapy for anti-NMDA receptor encephalitis
by: Atsuo Kanno, et al.
Published: (2025-06-01)

Development of a stable eukaryotic strain producing fully human monoclonal antibody on the basis of the human antibody against ectromelia virus
by: A. L. Matveev, et al.
Published: (2018-01-01)

Can Antinuclear Antibodies (ANA) be Monoclonal?
by: Laura Biederman, et al.
Published: (2021-01-01)

Bibliometric analysis of monoclonal antibodies for atherosclerosis
by: Jiqing Ma, et al.
Published: (2023-12-01)

Production and application of monoclonal antibodies to GST
by: WU Jian-xiang, et al.
Published: (2006-07-01)

First available biosimilar monoclonal antibodies
by: Zh. I. Avdeeva, et al.
Published: (2018-02-01)

Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2024-10-01)

IMMUNOTHERAPY IN ALL: MONOCLONAL ANTIBODIES AND BEYOND
by: Fatma Arıkan
Published: (2024-12-01)

Anti-amyloid Monoclonal Antibodies for Alzheimer’s Disease: A New Hope? (Review)
by: I. A. Mazerkina
Published: (2025-04-01)

Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis
by: Paola De Benedictis, et al.
Published: (2016-03-01)

Packaging of humanized anti-HER2 monoclonal antibody into small extracellular vesicles
by: Junxin Mai, et al.
Published: (2025-06-01)

Immune regulatory adjuvant approach to mitigate subcutaneous immunogenicity of monoclonal antibodies
by: Nicole L. Jarvi, et al.
Published: (2024-12-01)

Optimizing a human monoclonal antibody for better neutralization of SARS-CoV-2
by: Qian Wang, et al.
Published: (2025-07-01)

Off-Label Use of Monoclonal Antibodies for Eosinophilic Esophagitis in Humans: A Scoping Review
by: Benyu Yang, et al.
Published: (2024-11-01)

Protective porcine influenza virus-specific monoclonal antibodies recognize similar haemagglutinin epitopes as humans.
by: Barbara Holzer, et al.
Published: (2021-03-01)

New Monoclonal Antibodies for the Diagnosis of Influenza and other Acute Respiratory Viral Infections
by: A. A. Sominina, et al.
Published: (2015-10-01)

The efficacy and safety of sarilumab, fully human monoclonal antibodies against interleukin 6 receptor, in rheumatoid arthritis: new evidence
by: E. L. Nasonov, et al.
Published: (2019-11-01)

Experience with the use of recombinant humanized monoclonal antibodies to the human receptor for interleukin-6 in patients with CoVID-19
by: D. А. Gusev, et al.
Published: (2020-08-01)

Toxicokinetics of a humanized anti-cocaine monoclonal antibody in male and female rats and lack of cross-reactivity
by: Rose P. Webster, et al.
Published: (2023-12-01)

Impact of Monoclonal Antibody Aggregates on Effector Function Characterization
by: Wendy J. Walton, et al.
Published: (2025-04-01)

Monoclonal Antibodies as Immune Modulators for Cancer Therapy
by: Robert O Dillman
Published: (1992-01-01)

Prospects of pharmacotherapy for rheumatoid arthritis: Monoclonal antibodies
by: Evgeny Lvovich Nasonov, et al.
Published: (2012-06-01)

The effect of CGRP monoclonal antibodies on cardiovascular disease
by: Adam Sinker, et al.
Published: (2025-07-01)

Alemtuzumab and Natalizumab: The Monoclonal Antibody Story Continues
by: BL Johnston, et al.
Published: (2006-01-01)

Treatment with monoclonal antibodies in cancer - efficacy and prospects
by: Bartosz Omasta, et al.
Published: (2025-02-01)

Monoclonal Antibodies: from Development to Clinical Application
by: YuI Budchanov
Published: (2016-07-01)

Corrigendum: Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2025-02-01)

HIV monoclonal antibodies: a new opportunity to further reduce mother-to-child HIV transmission.
by: Yegor Voronin, et al.
Published: (2014-04-01)

Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
by: Jan ter Meulen, et al.
Published: (2006-07-01)

Cancer therapy via neoepitope-specific monoclonal antibody cocktails
by: Colin J. Hartman, et al.
Published: (2025-05-01)